Top Section
Top Section
◆ Deal finds demand despite arrest of South Korea's president ◆ High single digit concession left for investors ◆ Leads added spread to calm concerns
South Korean policy lender kickstarts 2025 funding following a month of political chaos
Singaporean and South Korean lenders expected to be regular euro issuers
More articles
More articles
More articles
-
Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times. -
Chinese online travel agency Tongcheng-Elong Holdings is making its debut in the offshore loan market for $200m.
-
Acme Solar Holdings was one of the few borrowers in Asia to brave volatile market conditions on Thursday to sell its debut dollar bond.
-
Louis Dreyfus Co Asia has become the latest commodities company to tap the debt market, seeking a $450m sustainability-linked loan that is being widely syndicated.
-
Chinese stocks were in freefall this week after Beijing tightened rules for the for-profit education sector, sparking a fresh — and severe — bout of volatility in the equities market. While the timing for new IPOs is far from ideal, there is hope yet for companies, say ECM bankers. Jonathan Breen reports.
-
HK Inno.N Corp, a South Korean pharmaceuticals company known for its popular hangover tonics, has priced its IPO at the top of the marketed range, netting W596.9bn ($520.9m).
shared comment list
